However, owing to the use of exogenous promoters to drive transgene expression, tau pathology does not occur in brain regions typically affected in AD or progress in a neuronal-network-dependent pattern, as would be expected if tau pathology spread were solely due to transneuronal transmission, in these models. The gene discussed is MAPT; the disease is Alzheimer disease.